Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Might be of interest to you: XEN,looking very promising...
chance of this recovering from this drop, just speculating to get in at the bottom, but is this the bottom? and how long till any sort of rise? sorry i'm still a newbie, i know a lot of brokers are rating this as buy/strong
Riddler what are your thoughts on summ now, are we at the bottom? Thinking of averaging down soon as news can't be far off IMHO. Interesting that they are at AZ in Alderley Park! Just round the corner from me.... Mat try and pop along if any one can register.... Now sat at a sizeable paper loss here but have faith. Good thing everything else is in the blue!
Good entry point? Is a buy on British bulls... sold out a few weeks ago....
Looks to me the market makers are sitting on a huge position here - one that they will want to off-load at a higher price than current - just my take on things (so could see a dead-cat-bounce here soon) - your thoughts riddler?
Surprised its gone this low - what say you?
Thanks riddler What assets have they to set of aginst the impending loses? like you I feel the same re buy back . Cleared my holdings at the last peak
Having seen nothing to the contrary can I assume that the Company is still debt free ? Anybody out there who can advise on their status
well thank goodness for stop-loss triggers - they have their uses after all
This is a set back. Not only is it bad news but they have failed to update on whether this order will now be fulfilled, halved or canceled. In my opinion the management team need to sell this business to a company with the capability of developing and selling their products. They have had a shot at making it work and they haven’t delivered. If your team doesn’t deliver you look to the management team. If I were Mr Akers I would be on the phone EKF !
You are fortunate indeed,still I will stay in here and wait for,hopefully,better news.
Delays are hopefully just that with the end result being the same
Thomas A. Nicolette, Chief Executive of ABI, commented, "Although we were profoundly disappointed in the severe delay related to our supply agreement with Pulse, the increase in PIFA sales, the market acceptance of the BreathScan alcohol awareness programmes, and our pending product launches keep us focused on success during 2012."
Trading Update Akers Biosciences, Inc. (AIM:AKR), is an innovative designer and manufacturer of rapid diagnostic screening and testing products. The Company announces that chiefly due to issues with an order from Pulse Health, revenues for 2011 will be significantly below expectation with turnover expected to be approximately US $2.2M and that consequently proforma losses will be in the region of US $1.9M, though these figures may be subject to change. In June 2011, it was announced that ABI had secured a purchase order totaling US$3,242,200 to manufacture and supply Revelar Breath Tubes to Pulse Health, LLC under the Company's supply agreement. This was the first purchase order under the supply agreement and manufacturing commenced immediately at ABI's New Jersey facility. It was anticipated that the majority of this order would be fulfilled during 2011. In the latter part of 2011, Pulse experienced difficulties in the manufacture of their reagent which was to be supplied to ABI. This resulted in severe delays in the Company's production schedule. ABI continues to manufacture the Tubes currently, but the quantities delivered to Pulse are lower than originally planned due to Pulse's reagent formulation problems. As a result of these events that were out of the Company's control, it is with regret that ABI informs the market that turnover in relation to the Revelar Breath Tubes during 2011 will be approximately US$1.2M lower than expected. In addition, sales of BreathScan, the Company's line of disposable breath alcohol detectors have slowed over the prior year, partially due to the US government's failure to achieve the passing of its budget. This has lead to a strategic shift in the way ABI will structure its breath alcohol business segment. Moving forward, the products will be integrated into comprehensive alcohol awareness programmes focused on government and corporate sectors. To view the new initiative, please visit www.breathscan.com With regard to the Company's core product, sales of the PIFA Heparin/PF4 Rapid Assay continued to show improvement during 2011 with revenues approximately 23 per cent higher than in 2010. (PIFA sales 2011, H1 $583,473; H2 $643,192). The PIFA HPF4 test is the only FDA-cleared device that quickly determines if a patient, being treated with the blood thinner Heparin, may be developing a drug allergy that can result in life- and limb-threatening blood clots. Q1 2012 will mark the launch of the PIFA PLUSS PF4 rapid assay, a product line extension of ABI's growing heparin-allergy platform.
http://www.investegate.co.uk/Article.aspx?id=201201060700111027V
All the very best to you for 2012...
Hope you are still holding the fort!Always reading your posts. I would like to wish you a very happy and prosperous new year...
Surprised you got caught,hard luck...
first buy of the day, can we continue the nice rise from last week? a few profit takers exited the market too.
i expect some news next week on trials. before xmas and maybe a trading update to boot.
what does 990 share mean again!?
looks like we could see over 2.5-3mm trades today if not more
Fine thanks,decided to increase my holding here for now,still looking@PIM...ATB
Has been very tempting to sell,got some more yesterday&today instead...
yep. still a few big buys again after 4pm. Should be another good day tomorrow, especially if we get some news!